What’s New!

REPORTS

EDBI Commemorates 30 Years of Investing to Shape Singapore’s Future

The Upside – EDBI E-Newsletter 2022 Q2
We continue to focus on value creation efforts for our portfolio companies.
Southeast Asia Fintech Report 2022
Southeast Asia's Fintech landscape is in a phase of rapid growth. The accelerated digitalisation due to the pandemic and new offerings from Fintech players have provided significant tailwinds for the sector.

The Sustainable Recipe to Feed the World

Dive into China and Southeast Asia's agrifood landscape, and what the future holds

The Upside – EDBI E-Newsletter 2022 Q2

We continue to focus on value creation efforts for our portfolio companies.

The Upside – EDBI E-Newsletter 2022 Q1

Presenting a fresh look for our quarterly e-newsletter, The Upside.

Southeast Asia Fintech Report 2022

Southeast Asia's Fintech landscape is in a phase of rapid growth. The accelerated digitalisation due to the pandemic and new offerings from Fintech players have provided significant tailwinds for the sector.

EDBI Newsletter 2021 Q4

Groundbreaking initiatives and portfolio companies’ achievements in 2021

EDBI Newsletter 2021 Q3

EDBI announces new pathbreaking initiatives and celebrates our portfolio companies’ public listings and world-leading achievements

EDBI Newsletter 2021 Q2

EDBI portfolio companies Sprinklr and WalkMe debuted on the NYSE and NASDAQ respectively in June, bringing the number of IPOs from our portfolio this year to three, joining Appier which listed on the TSE in March.

EDBI Newsletter 2021 Q1

SPAC wave arrives in Southeast Asia. The ongoing surge of SPAC-related activities in the US arrived on the shores of Southeast Asia in recent months, with Grab announcing their record-breaking deal and planned NASDAQ listing followed by news of other SPAC developments from the likes of Traveloka, PropertyGuru and Bukalapak as well as regulatory consultations by regional bourses including in Singapore and Indonesia, underscoring the region’s ability to produce successful global companies.

EDBI Newsletter 2020 Q4

As 2020 comes to a close, team EDBI took the opportunity to reflect on the market activity and outlook for 2021.

Enhancing the development of the ASEAN markets and accelerating global market expansion for Chinese biopharma companies

Take a deep dive into the ASEAN biopharmaceutical landscape